BAMCO Inc’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-30,300
Closed -$2.63M 371
2018
Q1
$2.63M Buy
30,300
+9,000
+42% +$727K 0.01% 260
2017
Q4
$1.47M Hold
21,300
0.01% 284
2017
Q3
$1.94M Hold
21,300
0.01% 274
2017
Q2
$1.58M Buy
21,300
+5,000
+31% +$401K 0.01% 284
2017
Q1
$1.53M Hold
16,300
0.01% 278
2016
Q4
$1.18M Buy
16,300
+9,500
+140% +$813K 0.01% 277
2016
Q3
$710K Buy
6,800
+1,300
+24% +$117K ﹤0.01% 285
2016
Q2
$406K Buy
5,500
+3,000
+120% +$204K ﹤0.01% 282
2016
Q1
$141K Buy
+2,500
New +$147K ﹤0.01% 288

Other funds holding NVRO

BAMCO Inc's NVRO Position: Q2 2018 in Review

BAMCO Inc sold out of NEVRO CORP. (NVRO) in Q2 2018, closing a stake of 30,300 shares — an estimated $2.63M sold.

BAMCO Inc first reported a position in NVRO in Q1 2016 and held it in 9 quarters. The position peaked at $2.63M in Q1 2018. 192 funds tracked by Wall St. Rank hold NVRO as of Q2 2018.

  • BAMCO Inc reported no remaining NEVRO CORP. position as of Q2 2018 after selling out during the quarter.
  • BAMCO Inc sold 30,300 NEVRO CORP. shares in Q2 2018, an estimated $2.63M.
  • BAMCO Inc first reported a position in NEVRO CORP. in Q1 2016 and held it in 9 quarters.
  • BAMCO Inc's NEVRO CORP. position peaked at $2.63M in Q1 2018.
  • 192 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2018.

Based on BAMCO Inc's 13F filing for Q2 2018, filed 14 Aug 2018.